MMP23B

MMP23B is an atypical matrix metalloproteinase containing a catalytic domain with the consensus HEXXH zinc-binding motif but lacking the conserved cysteine switch residue used for autoinhibition, and featuring unique cysteine-rich and interleukin-1 receptor-related domains (PMID:9740677). MMP23B directly interacts with TNF and mediates its release from the cell membrane, functioning upstream of TNF signaling to promote hepatocyte proliferation during liver development, as established by genetic epistasis in zebrafish where TNF overexpression rescued mmp23b loss-of-function but not vice versa (PMID:21064033). In endometrial cancer cells, MMP23B promotes cell survival, migration, and invasion while suppressing caspase-mediated apoptosis (PMID:38782818), and in intestinal epithelium it regulates tight junction integrity and mitochondrial function, with conditional knockout mice showing protection against mucosal barrier disruption (PMID:39280187).

1. 1998 Medium

   Identification of MMP23B as a structurally atypical metalloproteinase — possessing the HEXXH zinc-binding catalytic motif but lacking the canonical cysteine switch — established that the MMP family includes members with fundamentally different activation mechanisms and novel domain architectures (cysteine-rich and IL-1 receptor-related domains).

   Evidence Gene isolation, sequence characterization, and domain analysis of human chromosome 1p36.3

   PMID:9740677 PMID:9750192

   Open questions at the time

   • No enzymatic activity assay was performed to confirm catalytic function
   • Substrate specificity unknown
   • No structural model of the protein
2. 2010 High

   Demonstration that MMP23B acts upstream of TNF signaling to control hepatocyte proliferation answered how this protease connects to a defined developmental signaling pathway: it physically interacts with TNF and mediates its membrane release, placing it as a TNF-processing enzyme required for liver organogenesis.

   Evidence Morpholino knockdown and reciprocal mRNA rescue epistasis in zebrafish; biochemical interaction and membrane-release assays in human cell culture

   PMID:21064033

   Open questions at the time

   • Whether MMP23B directly cleaves TNF or releases it through an indirect mechanism was not resolved
   • Mammalian in vivo confirmation of the liver development role is lacking
   • Relationship to TACE/ADAM17-mediated TNF shedding is undefined
3. 2024 Medium

   Functional studies in cancer cells and intestinal epithelium expanded MMP23B's roles beyond TNF processing, revealing it promotes cell survival by suppressing caspase-dependent apoptosis and regulates epithelial barrier integrity through tight junction and mitochondrial homeostasis.

   Evidence siRNA knockdown in endometrial cancer cells with viability, migration, invasion, and caspase expression assays; intestinal epithelial-specific conditional knockout (Villin-MMP23B flox/flox) mice with tight junction and mitochondrial readouts

   PMID:38782818 PMID:39280187

   Open questions at the time

   • Direct substrates mediating the anti-apoptotic and tight junction effects are unknown
   • Whether the barrier and survival phenotypes depend on TNF signaling is untested
   • Findings are each from single laboratories without independent replication

• The direct enzymatic substrates of MMP23B, the structural basis for its atypical activation mechanism, and the extent to which its diverse biological effects (TNF processing, anti-apoptosis, barrier regulation) share a common proteolytic mechanism remain unresolved.
• No in vitro substrate cleavage assay has been reported
• No crystal or cryo-EM structure exists
• Physiological redundancy with the nearly identical MMP21/MMP23A paralog is unexplored